Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086150 · ClinicalTrials.gov registry record · Phase 2
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
A Phase 2 study, sponsored by Albany Medical College.
- Completed
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
NCT01086150 is a Phase 2 study that has completed, run by Albany Medical College. The registered enrollment target is 51 participants.
The verdict
NCT01086150, a Phase 2 study, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to see if an investigational drug known as the lidocaine 5% patch is safe and effective in reducing the symptoms of diabetic neuropathy, to examine how topical lidocaine affects the nerve endings, and to determine whether treatment with the lidocaine patch can prevent the potential progression to chronic diabetic neuropathy pain in subjects who did not report pain at the start of the study.
Interventions
- PROCEDURE Skin biopsy
- DRUG Lidocaine 5% patches
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2009-10 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01086150
The ClinicalTrials.gov registry entry for NCT01086150 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Skin biopsy is the first listed.
NCT01086150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01086150 about?
NCT01086150 is a clinical study titled "Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy". The purpose of this study is to see if an investigational drug known as the lidocaine 5% patch is safe and effective in reducing the symptoms of diabetic neuropathy, to examine how topical lidocaine affects the nerve endings, and to determine whether treatment with the lidocaine patch can prevent th...
What is the current status of trial NCT01086150?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2009-10. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01086150?
The interventions under investigation include: Skin biopsy (PROCEDURE), Lidocaine 5% patches (DRUG).
Who is sponsoring clinical trial NCT01086150?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.